[Post-transplant infectious diseases]

Rinsho Ketsueki. 2014 Oct;55(10):2136-41.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Antifungal Agents / administration & dosage
  • Antiviral Agents / administration & dosage
  • Bacterial Infections / drug therapy
  • Bacterial Infections / etiology*
  • Bacterial Infections / prevention & control*
  • Cytomegalovirus Infections / drug therapy
  • Cytomegalovirus Infections / etiology
  • Cytomegalovirus Infections / prevention & control
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Mycoses / drug therapy
  • Mycoses / etiology*
  • Mycoses / prevention & control*
  • Practice Guidelines as Topic
  • Toxoplasmosis / drug therapy
  • Toxoplasmosis / etiology
  • Toxoplasmosis / prevention & control
  • Virus Diseases / drug therapy
  • Virus Diseases / etiology*
  • Virus Diseases / prevention & control*

Substances

  • Anti-Bacterial Agents
  • Antifungal Agents
  • Antiviral Agents